Cancer Centers Assistance for Renovations and Expansion Act of 2020
This bill temporarily establishes and provides funds for a cancer center construction grant program for capital costs associated with research, prevention, or patient care infrastructure improvements.
[Congressional Bills 116th Congress]
[From the U.S. Government Publishing Office]
[H.R. 9049 Introduced in House (IH)]
<DOC>
116th CONGRESS
2d Session
H. R. 9049
To amend title XVIII of the Social Security Act to establish a cancer
center construction grant program.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
December 24, 2020
Mr. Higgins of New York introduced the following bill; which was
referred to the Committee on Energy and Commerce, and in addition to
the Committee on Ways and Means, for a period to be subsequently
determined by the Speaker, in each case for consideration of such
provisions as fall within the jurisdiction of the committee concerned
_______________________________________________________________________
A BILL
To amend title XVIII of the Social Security Act to establish a cancer
center construction grant program.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Cancer Centers Assistance for
Renovations and Expansion Act of 2020''.
SEC. 2. CANCER CENTER CONSTRUCTION GRANT PROGRAM.
The Social Security Act is amended by inserting after section 1897
the following new section:
``cancer center construction grant program
``Sec. 1897A. (a) Establishment.--The Secretary shall establish a
program to award grants to qualifying cancer centers (as defined in
subsection (b)) for payment of the capital costs of projects for the
improvement of research, prevention, or patient care infrastructure.
``(b) Qualifying Cancer Center and Other Definitions.--In this
section:
``(1) The term `qualifying cancer center' means an entity
that is designated as a comprehensive cancer center by the
National Cancer Institute.
``(2) The term `project for the improvement of research,
prevention, or patient care infrastructure' means--
``(A) the expansion, remodeling, renovating, or
altering of an existing clinical, prevention, or
research facility; or
``(B) the construction of a new clinical,
prevention, or research facility.
``(3) The term `intended use' means the purposes for which
the infrastructure improvements were made.
``(4) The term `shovel ready' means, with respect to a
project, that construction of the project will be completed
within 5 years of the date on which a grant for such project is
provided under this section.
``(c) Application; Qualifications; Terms of Grants.--
``(1) In general.--No grant may be awarded under this
section to a qualifying cancer center except pursuant to an
application that is submitted and approved in a time, manner,
and form specified by the Secretary.
``(2) Qualifications.--A grant may not be provided under
this section for a project for a qualifying cancer center
unless the applicant--
``(A) provides assurances satisfactory to the
Secretary that--
``(i) the project--
``(I) is for the improvement of
research, prevention, or patient care
infrastructure of the center;
``(II) is shovel ready; and
``(III) will expand the applicant's
capacity for research, prevention or
patient care, or is necessary to
improve or maintain the quality of the
applicant's research, prevention, or
patient care; and
``(ii) the applicant will--
``(I) have sufficient funds to meet
the non-Federal share of the cost of
the infrastructure improvement;
``(II) use the facility improved or
resulting from the project for its
intended use for a period of at least
20 years after completion of the
project and has sufficient funds
available to demonstrate effective use
of such facility for its intended use;
``(III) facilitate reasonable depth
and breadth of research activities in
each of the three major areas of
laboratory research, clinical research,
and population-based research, with
substantial transdisciplinary research
that bridges these scientific areas;
``(IV) initiate and conduct
investigator-initiated, early phase,
innovative clinical trials;
``(V) perform community service,
outreach, dissemination, and education
and training of biomedical researchers
and health care professionals; and
``(VI) develop and implement
strategies or activities designed to
reduce racial or ethnic, gender, age,
or socioeconomic health disparities in
cancer research, cancer care, cancer
patient outcomes, or directly in the
communities in which the center is
located; and
``(B) provides an estimate of the number of jobs
that will be created by such project.
``(3) No further requirements.--The Secretary shall not
promulgate any further requirements or restrictions on a
qualifying cancer center to obtain assistance under this
section other than those specified in this section.
``(4) Terms of grants.--
``(A) In general.--Grants under this section shall
be made consistent with the requirements of this
section.
``(B) Limitations on grants.--The maximum,
aggregate amount of grants that may be made under this
section (and for which reimbursement may be provided
under subsection (d)(2)) for a qualifying cancer center
is 75 percent of the total project costs, but not to
exceed $25,000,000.
``(d) Funding.--
``(1) In general.--To carry out this section, there are
appropriated out of amounts in the Treasury not otherwise
appropriated, $900,000,000.
``(2) Administrative costs.--For the administration of this
section, Secretary may not use more than $1,000,000 from the
funds made available under paragraph (1) for fiscal years 2021
through 2023.
``(3) Availability.--Amounts appropriated under this
section shall be available for obligation and obligated during
the period beginning on October 1, 2020, and ending on
September 30, 2023.
``(e) Report to Congress.--Not later than 3 years after the date of
the enactment of this section, the Secretary shall submit to Congress a
report on the projects for which grants are provided under this section
and a recommendation as to whether the Congress should authorize the
Secretary to continue grants under this section beyond fiscal year
2023. For each applicant awarded a grant under this section, such
report shall include an evaluation of whether such applicant has
performed the actions described in each of subclauses (II) through (VI)
of subsection (c)(1)(A)(ii), including whether such applicant has
developed and implemented strategies or activities designed to reduce
racial or ethnic, gender, age, or socioeconomic health disparities in
cancer research, cancer care, cancer patient outcomes, or directly in
the communities in which the center is located.''.
<all>
Introduced in House
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Llama 3.2 · runs locally in your browser
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line